Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Overcoming Psychiatric Barriers to the Treatment of Hepatitis C

This study has been completed.
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
Donna Evon, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT00407732
First received: December 4, 2006
Last updated: January 24, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)